Literature DB >> 1829571

Assessment of the extent of jeopardized myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging.

M Pfisterer1, J Müller-Brand, P Spring, V Bassignana, W Kiowski.   

Abstract

We tested the feasibility of technetium-99m methoxyisobutyl isonitrile (Tc-MIBI) imaging for delineating jeopardized myocardium during acute coronary occlusion and reperfusion in man. This new perfusion agent was injected in 25 patients during elective percutaneous transluminal coronary angioplasty (PTCA) of a single-vessel left anterior descending (LAD) coronary artery stenosis. Distinct perfusion defects were present on "occlusion" images but not on "open vessel" images obtained 20 to 24 hours later in 21 patients (84%). The extent and severity of perfusion defects were significantly smaller in patients with distal versus proximal LAD occlusions (3.4 +/- 1.2 versus 5.2 +/- 1.5 segments; p less than 0.001). The only factor that was significantly related to the presence or absence of such "ischemic" perfusion defects was the absence or presence of visible collateral vessels to the LAD (p less than 0.03). The site of occlusion, presence of wall motion abnormalities, or occlusion time did not influence the results significantly. Thus the myocardial area at risk could be visualized and quantitated by Tc-MIBI imaging even after occlusion times as short as 15 seconds, but functioning collateral vessels are capable of protecting jeopardized myocardium in this setting.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829571     DOI: 10.1016/0002-8703(91)90751-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

2.  Nuclear cardiology: the interventionalists' perspective.

Authors:  H L Haronian; H S Cabin
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

3.  Residual area at risk after anterior myocardial infarction: are ST segment changes during coronary angioplasty a reliable indicator? A comparison with technetium 99m-labeled sestamibi single-photon emission computed tomography.

Authors:  M Faraggi; P G Steg; D Francois; L Sarda; J M Foult; D Daou; P Assayag; D Le Guludec
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

Review 4.  The role of scintigraphic techniques in the evaluation of functional results of coronary bypass grafting and percutaneous transluminal coronary angioplasty.

Authors:  A F Kuijper; B L van Eck-Smit; M G Niemeyer; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Int J Card Imaging       Date:  1993

5.  Myocardial perfusion imaging after transient balloon occlusion during percutaneous coronary interventions.

Authors:  Raed Aqel; Gilbert J Zoghbi; Luvenia W Bender; Johnny W Scott; Jon A Baldwin; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

6.  Assessment of area at risk and efficacy of treatment in patients with acute coronary syndrome using 99mTc tetrofosmin imaging in humans.

Authors:  H Matsuo; S Watanabe; Y Nishida; T Matsubara; M Kano; A Sugiyama; Y Matsuno; H Oda; Y Kotoo; H Oohashi
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

7.  Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.

Authors:  Carlo Trani; Alessandro Giordano; Antonella Lombardo; Alessandro Lupi; Francesca Reale; Roberto Patrizi; Giampiero Patrizi; Mario A Mazzari; Giovanni Schiavoni; Attilio Maseri
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.